WNK2 and thyroid gland carcinoma: The constitutive aberrant activation of mitogen-activated protein kinase (MAPK) signaling (also known as the RAS-RAF-MEK-ERK signaling pathway), which normally regulates physiological proliferative events, is frequently found in thyroid cancers.